// App-Quantinova.ai

: Aberrant Proportion of Monocyte Subsets in Bone Marrow of High-Risk Myelodysplastic Syndrome Patients

Researchers

Presenter

  • Richa Rai

Principal Investigators

  • Camille Bigenwald

  • Jonathan Feld

  • Stella Melana

  • Erin P. Demakos

  • Amir Horowitz

  • Lewis R. Silverman

Medical Centers

  • Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

  • Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY

  • Gustave Roussy Institute, Villejuif, France

Locations

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Alpha-thalassemia myelodysplasia syndrome

Biomarkers

  • Monocyte

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved